Excessive Daytime SleepinessSymptoms, Doctors, Treatments, Advances & More
Excessive Daytime Sleepiness Overview
Learn About Excessive Daytime Sleepiness
Montefiore At 3411 Wayne Avenue
Michael J. Thorpy, MD, is Director, Sleep-Wake Disorders Center at Montefiore and Professor of Neurology at our Albert Einstein College of Medicine. His clinical focus is on the clinical diagnosis, evaluation and treatment of all sleep disorders, including sleep apnea, narcolepsy, insomnia and restless legs syndrome, among others. Dr. Thorpy is rated as an Elite provider by MediFind in the treatment of Excessive Daytime Sleepiness. His top areas of expertise are Narcolepsy, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, and ADULT Syndrome.
Susan Redline is a Cardiologist and a Sleep Medicine provider in Cleveland, Ohio. Dr. Redline is rated as an Elite provider by MediFind in the treatment of Excessive Daytime Sleepiness. Her top areas of expertise are Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Cerebral Hypoxia, Central Sleep Apnea, and Adenoidectomy.
Geisinger Medical Center - Pediatric Neurology
Dr. Morse is a board-certified and fellowship-trained pediatric neurologist. Her clinical interests include sleep-wake disorders in neurologic disease, narcolepsy and hypersomnia disorders and neuroimmunology. Her research interests include sleep-wake disorders in neurologic disease, hypersomnia disorders and sleep-wake disorder phenotyping. Dr. Morse earned her degree in osteopathy from Rowan University. She completed her residency and her child neurology fellowship at the State University of New York, Downstate Medical Center. She completed another fellowship in sleep medicine at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. Dr. Morse is certified by the American Board of Psychiatry and Neurology in neurology with special qualification in child neurology.|Video: more from Dr. Anne Morse, M.D. Dr. Morse is rated as an Elite provider by MediFind in the treatment of Excessive Daytime Sleepiness. Her top areas of expertise are Narcolepsy, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, and Sleep Paralysis.
Summary: Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
Summary: This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant in patients living with Prader-Willi syndrome. The primary objective of this study is to evaluate the efficacy of pitolisant in treating excessive daytime sleepiness (EDS) in patients ≥6 years of age with Prader-Willi syndrome. Secondary objectives inc...


